Riyadh - Sharikat Mubasher: Saudi investment company Merak Capital co-led a $1.65 million investment round for the healthcare technology company, Hakeem Health, alongside Sanabil 500, as part of its strategy to support high-growth technology companies.
In an official statement released today, Merak Capital revealed that the investment will help Hakeem Health accelerate institutional adoption of HakeemDx across the GCC, as regional healthcare systems increasingly look to AI to drive clinical efficiency and quality of care.
Hakeem Health develops an AI-powered medical assistant that delivers real-time, evidence-based clinical insights at the point of care in multiple languages. Its flagship platform, HakeemDx, is a clinical decision support engine that integrates with hospital systems, including EMRs and lab platforms, to deliver real-time, bilingual (Arabic/English), evidence-based guidance to clinicians at the point of care, reducing medical errors and supporting better patient outcomes.
This investment reflects Merak Capital’s commitment to the Saudi Vision 2030, supporting digital transformation and the development of knowledge-based industries.
Abdulelah Alshareef, Principal of Venture Capital at Merak Capital, said: “AI is already delivering measurable productivity gains across industries, and healthcare remains a critical area for impact. Hakeem addresses key challenges in clinical decision-making by enabling faster, more accurate assessments that can improve patient outcomes.”
For his part, Bilal Adi, Founder and CEO of Hakeem Health, emphasized the company’s mission to help clinicians make better decisions faster, providing patients with better care. “Merak Capital’s investment reinforces that mission and supports the next phase of our growth. This funding enables us to expand our platform “HakeemDx” across hospitals and health systems in the GCC and continue building AI solutions that clinicians trust,” he added.
Hakeem Health targets institutional adoption across hospitals, universities, and healthcare payers through recurring contracts. With more than 2,000 hospitals across key regional markets, including Saudi Arabia, the UAE, and Egypt, the company is positioned for regional growth.
